Cancidas
Fungal Meningitis Patients: A Long Road to Recovery »
"Dec. 26, 2012 -- Johnnie McKee thought she was out of the woods.
McKee, a 72-year-old grandmother of four from Bethpage, Tenn., was one of nearly 14,000 people who found out this fall that they'd been exposed to tainted medications made by "...
Read the Fungal Meningitis Patients: A Long Road to Recovery article »
Cancidas
OVERDOSE
In 6 healthy subjects who received a single 210-mg dose, no significant adverse reactions were reported. Multiple doses above 150 mg daily have not been studied. Caspofungin is not dialyzable. The minimum lethal dose of caspofungin in rats was 50 mg/kg, a dose which is equivalent to 10 times the recommended daily dose based on relative body surface area comparison.
In clinical trials, one pediatric patient (16 years of age) unintentionally received a single dose of caspofungin of 113 mg (on Day 1), followed by 80 mg daily for an additional 7 days. No clinically significant adverse reactions were reported.
CONTRAINDICATIONS
CANCIDAS is contraindicated in patients with hypersensitivity (e.g., anaphylaxis) to any component of this product [see ADVERSE REACTIONS].
Last reviewed on RxList: 1/30/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Cancidas Information
Cancidas - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.






